Aptevo Therapeutics announces at-the-market stock offering of up to $2.31 million
Bitget2026/11/02 11:04- Aptevo Therapeutics plans to offer up to $2.31 million in common stock under its existing at-the-market offering agreement.
- Roth Capital Partners serves as sales agent under the agreement dated April 28, 2025.
- Previous sales under the agreement totaled 303,157 shares, generating $11.8 million in gross proceeds.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SoftBank develops contingency plans for slowdown in US data center business, considers shifting to other countries
A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.
Quantumrail Cancels 10 Billion Won Convertible Bond Offering
Crypto prices
More
